MedPath

Xenon, Xe-133

Xenon Xe 133 GasRx only Diagnostic

Approved
Approval ID

5eb971be-8808-4aeb-9898-0d22d5dffe04

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 15, 2022

Manufacturers
FDA

Curium US LLC

DUNS: 079875617

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Xenon

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69945-097
Application NumberNDA018327
Product Classification
M
Marketing Category
C73594
G
Generic Name
Xenon
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateDecember 15, 2022
FDA Product Classification

INGREDIENTS (2)

XENON XE-133Active
Quantity: 5 mCi in 1 mL
Code: X3P9A5HNYF
Classification: ACTIB
AIRInactive
Code: K21NZZ5Y0B
Classification: IACT

Xenon

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69945-098
Application NumberNDA018327
Product Classification
M
Marketing Category
C73594
G
Generic Name
Xenon
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateDecember 15, 2022
FDA Product Classification

INGREDIENTS (2)

XENON XE-133Active
Quantity: 10 mCi in 1 mL
Code: X3P9A5HNYF
Classification: ACTIB
AIRInactive
Code: K21NZZ5Y0B
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Xenon, Xe-133 - FDA Drug Approval Details